Company Filing History:
Years Active: 1998-2001
Title: The Innovations of Daniel DiSepio
Introduction
Daniel DiSepio is a notable inventor based in Corona del Mar, California. He has made significant contributions to the field of biotechnology, particularly in the area of retinoid-induced gene research. With a total of 2 patents, his work has implications for cancer research and treatment.
Latest Patents
DiSepio's latest patents include a novel human cDNA known as TIG3 (Tazarotene Induced Gene 3). This gene is inducible by RAR-selective retinoids and is structurally related to a known tumor suppressor gene. Additionally, he has developed methods for detecting the TIG3 polynucleotide, which further enhances the understanding of its role in cancer biology.
Career Highlights
Throughout his career, DiSepio has worked with prominent companies such as Allergan, Inc. and Allergan Sales, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Sunil Nagpal and Roshantha A Chandraratna. Their collaborative efforts have likely played a role in advancing the research and development of innovative solutions in biotechnology.
Conclusion
Daniel DiSepio's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer research and treatment.